Breaking news
Britain will have to pay almost £2,000-per-patient for one of the only two approved Covid-19 drugs, it was revealed today. Gilead Sciences announced it would charge governments of developed countries $390 (£320) per vial of remdesivir. Most hospitalised patients will need six vials of the Ebola drug — equating to $2,340 (£1,900) for every patient, … Read more
Britain’s youngest Covid-19 survivor: Parents’ joy as three-months premature Emmanuel wins a 47-day fight with the virus before he was even due to be born Three-month-old Emmanuel Boateng is believed to be UK’s youngest survivor He spent nearly two months in hospital on a ventilator to help him breathe Emmanuel was born at just 27 weeks and taken to … Read more
Test can diagnose coronavirus in just 30 minutes by analysing urine, blood or saliva samples is developed by scientists Method known as reverse transcription loop-mediated isothermal amplification Has been previously used to detect viruses such as Zika and Ebola Method involves looking for genetic material, or RNA, of the coronavirus in the test samples Here’s how … Read more
Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more
Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more
Health chiefs grant NHS emergency access to give severely-ill Covid-19 patients promising Ebola drug remdesivir By Sam Blanchard Senior Health Reporter For Mailonline Published: 11:04 BST, 26 May 2020 | Updated: 11:05 BST, 26 May 2020 Coronavirus patients in Britain will now be treated with remdesivir, the Ebola drug which has shown promise in battling … Read more
A 14-year-old boy left critically ill by the coronavirus has survived his ordeal after being given the Ebola drug remdesivir, his family have revealed. Jacob Tayel, from Ipswich, fell ill with what his mother assumed was a chest infection in March, and his 11-year-old brother, Isaac, was ill at the same time. Dianne, their mother, … Read more
It may sound like a plot from a science fiction film, but NASA and scientists are concerned about alien viruses contaminating Earth. As the first humans prepare for the Mars mission, experts warn that protocols are necessary to keep extraterrestrial pollutants from hitchhiking on space ships and astronauts when returning home from the Red Planet. Stanford … Read more
Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company. Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more
The fight against coronavirus has been an uphill battle. Although we may be past the peak, hundreds are still dying every day, and often there is little doctors can do to save those hit by this mysterious disease. Yet eagerly awaited results of a ground-breaking medical trial have brought fresh hope. US researchers have published early … Read more